• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Envigo adds Craig Boyd and Lizanne Muller

Envigo adds Craig Boyd and Lizanne Muller

September 22, 2017
CenterWatch Staff

Envigo has made two new appointments to its Executive Committee. The appointments of a Chief Commercial Officer and President of EMEA Operations have been made at a time of growth for Envigo during which the organization has been focused on improving the quality of the customer experience for its global customer base across the pharmaceutical, chemicals, and crop protection industries. Both of the positions report directly into Dr. Adrian Hardy, Chief Executive Officer of Envigo.

Craig Boyd has joined Envigo in the position of Chief Commercial Officer.

Boyd has more than 20 years’ experience in various global pharmaceutical markets and has worked extensively in the U.S., Asia, Europe and Australia. A dynamic commercial leader, Boyd was the Executive Vice President of Mayne Pharma’s U.S. specialty brands division before joining Envigo. Prior to this, Boyd led the global commercial sales functions at Hospira and Mylan, and spent 10 years as a senior commercial sales and marketing executive at Novartis. In his new role, Boyd is responsible for Envigo’s global commercial organization, including, sales, marketing, pricing and customer service activities.

Lizanne Muller has joined Envigo as President EMEA Operations.

Muller has 18 years’ experience working within a multinational pharmaceutical manufacturing company, and brings with her extensive commercial experience, specializing in operational finance, continuous improvements, regulatory compliance and change management. Prior to joining Envigo, Muller spent 16 years at the Dishman Group serving in a variety of roles of increasing responsibility including Vice President of Compliance and Governance. Muller is accountable for Envigo’s Contract Research Services and Research Services Models operations across Europe and Asia.

"I am delighted that Boyd and Muller have joined the team at Envigo and both brought with them great experience and knowledge that has added huge value to the way we work", commented Adrian Hardy. "Their experience and expertise will help us grow Envigo as we continue to focus on delighting our customers with great products and services. It’s a really exciting time at Envigo right now, with emphasis on enhancing our customers’ experience of working with us and cementing our presence as leaders in the markets we serve.”

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing